MCL1 and acute myeloid leukemia: Thus, this study aims to explore the Mcl-1 binding potential and pharmacological viability of selected 1,2,4-triazolo[4,3-b]pyridazine derivatives through a robust computational framework, offering both mechanistic insights and a basis for future therapeutic development against AML.